Emily LeProust: Difference between revisions
m v2.04b - Bot T20 CW#61 - Fix errors for CW project (Reference before punctuation) |
added peer-reviewed references and more media |
||
| Line 1: | Line 1: | ||
{{Short description|American scientist and entrepreneur}} |
{{Short description|American scientist and entrepreneur}} |
||
'''Emily Leproust''' is an American scientist and entrepreneur. She is the CEO and co-founder<ref>[https://www.rosalindfranklinsociety.org/index.php?option=com_content&view=article&id=114:rfs-briefings---september-30--2020&catid=23:briefings&Itemid=136 RFS Briefings - September 30, 2020 Rosalind Franklin society]</ref> of [[Twist Bioscience]], a public company working on DNA synthesis. The company harnesses synthetic biology, providing tools |
'''Emily Leproust''' is an American scientist and entrepreneur. She is the CEO and co-founder<ref>[https://www.rosalindfranklinsociety.org/index.php?option=com_content&view=article&id=114:rfs-briefings---september-30--2020&catid=23:briefings&Itemid=136 RFS Briefings - September 30, 2020 Rosalind Franklin society]</ref> of [[Twist Bioscience]], a public company working on DNA synthesis. The company harnesses synthetic biology, providing tools to manufacture [[insulin]] from yeast, to tackle [[malaria]] <ref>[https://www.ted.com/talks/emily_leproust_how_synthetic_biology_can_improve_our_health_food_and_materials How Twist Bioscience is writing the future of sustainability. – TED ]</ref>, produce spider silk at scale<ref>[https://pod.co/sbb-podcast/how-dna-synthesis-is-powering-the-fourth-manufacturing-revolution-with-emily-leproust How DNA synthesis is powering the fourth manufacturing revolution - SynBioBeta Podcast, with Emily Leproust]</ref> or store information on DNA<ref>{{cite journal|doi=10.1038/nature11875}}</ref><ref>[https://www.nature.com/articles/d41586-021-00534-w Technology alliance boosts efforts to store data in DNA – Nature]</ref>. She was awarded the BIO Rosalind Franklin Award in 2020.<ref>[https://www.bio.org/press-release/bio-announces-2020-bio-impact-award-winners#:~:text=2020%20Rosalind%20Franklin%20Award%20Winner,improve%20human%20health%20and%20sustainability BIO Announces 2020 BIO IMPACT Award Winners – Biotechnology Innovation Organization]</ref> |
||
== Education and career == |
== Education and career == |
||
Revision as of 05:44, 23 March 2021
Emily Leproust is an American scientist and entrepreneur. She is the CEO and co-founder[1] of Twist Bioscience, a public company working on DNA synthesis. The company harnesses synthetic biology, providing tools to manufacture insulin from yeast, to tackle malaria [2], produce spider silk at scale[3] or store information on DNA[4][5]. She was awarded the BIO Rosalind Franklin Award in 2020.[6]
Education and career
Leproust earned an M.Sc. in Industrial Chemistry from the Lyon School of Industrial Chemistry[7] in 1995 and a PhD in Organic Chemistry & Nucleic Acids Chemistry from the University of Houston in 2001.[8] She worked for the company Agilent where she was Director of Applications and Chemistry R&D—Genomics before starting the company Twist Bioscience.
References
- ^ RFS Briefings - September 30, 2020 Rosalind Franklin society
- ^ How Twist Bioscience is writing the future of sustainability. – TED
- ^ How DNA synthesis is powering the fourth manufacturing revolution - SynBioBeta Podcast, with Emily Leproust
- ^ . doi:10.1038/nature11875.
{{cite journal}}: Cite journal requires|journal=(help); Missing or empty|title=(help) - ^ Technology alliance boosts efforts to store data in DNA – Nature
- ^ BIO Announces 2020 BIO IMPACT Award Winners – Biotechnology Innovation Organization
- ^ Sitting down with Emily Leproust, CEO, Twist Bioscience – Drug Discovery World
- ^ Asking All the Right Questions: Emily Leproust (’01), Top Global Thinker – University of Houston
External links
- Emily LeProust publications indexed by Google Scholar
| Authority control databases: Academics |
|---|
   | This article about an American scientist is a stub. You can help Wikipedia by expanding it. |
 | This article about a chief executive from the United States is a stub. You can help Wikipedia by expanding it. |